multi-valent vaccine
Scope
Date
~
-
Korean stock market
Samsung returns as foreigners’ top pick; Kospi just shy of record high
Samsung Electronics Co., the bellwether of South Korea’s main bourse, has returned as the market darling, with foreigners buying heavily on th...
Jun 03, 2021 (Gmt+09:00)
language -
Media
Naver to gain toehold in OTT market via CJ ENM
South Korea's Naver Corp. is expanding its footprint into the over-the-top (OTT) media service market by acquiring a stake in CJ ENM Co.'s OTT platf...
Jun 02, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience secures up to $173.4 mn from CEPI for vaccine development
SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...
May 24, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language -
COVID vaccines
Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine
South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...
May 12, 2021 (Gmt+09:00)
language -
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
COVID-19
Genexine exports COVID vaccine candidate to Indonesia
Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...
Apr 28, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience halts flu vaccine output to focus on COVID vaccines
South Korea’s SK Bioscience Co. is suspending production of SKYCellflu, an influenza vaccine, to focus on manufacturing COVID-19 vaccines inst...
Mar 30, 2021 (Gmt+09:00)
language -
COVID-19
Green Cross in talks with Russia to produce COVID-19 vaccine
South Korea’s pharmaceutical company Green Cross Corporation (GC) is holding a series of close meetings on contract manufacturing of Russia&rs...
Mar 18, 2021 (Gmt+09:00)
language -
Pension funds
NPS begins process to venture into multi-asset investments
South Korea’s National Pension Service (NPS) has begun a process to initiate multi-asset investment as part of an effort to create higher retu...
Feb 26, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience eyes $900 mn annual sales from vaccine business
South Korea’s SK Bioscience Co. is looking to post 1 trillion won ($900 million) in annual revenue from its vaccine business as the biopharmac...
Feb 23, 2021 (Gmt+09:00)
language -
Celltrion eyes COVID-19 vaccine development
South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...
Feb 19, 2021 (Gmt+09:00)
language -
Economy
Korea’s treasury yields climb on hopes of vaccines, more bond issues
South Korea’s treasury yields are heading higher as advances in vaccine development and concerns over increased government bond sales prompt f...
Dec 20, 2020 (Gmt+09:00)
-
COVID-19
Korea Superfreeze readies for mass COVID-19 vaccine storage
It's a busy day at the Korea Superfreeze warehouse in South Korea's Gyeonggi province, with trucks entering and exiting the spacious 92,500-square...
Dec 14, 2020 (Gmt+09:00)
-
Cold-chain logistics
SK Holdings cryogenic biz eyes jackpot on hopes of imminent COVID-19 vaccine
South Korea's SK Holdings Co. may hit the jackpot with the development of a COVID-19 vaccine on the horizon.Once a coronavirus vaccine is available, t...
Nov 13, 2020 (Gmt+09:00)
-
Multi asset funds
Yellow Umbrella Mutual to invest $500 mn in global multi-asset funds
The Yellow Umbrella Mutual Aid Fund, a $12 billion savings arm for South Korea’s small business owners, has entrusted two Korean asset managers ...
Oct 05, 2020 (Gmt+09:00)
-
COVID-19
SK Bioscience wins COVID-19 vaccine manufacturing order from US firm
SK Bioscience Co. Ltd. has secured a contract manufacturing organization (CMO) order for a new coronavirus vaccine candidate under development by the ...
Aug 14, 2020 (Gmt+09:00)
-
[RFP] Korea scientists fund to pick $120 mn multi-asset SMA manager
Korea Scientists and Engineers Mutual-aid Association (SEMA) is planning to allocate around $120 million to a separately managed account (SMA) of mult...
Oct 25, 2017 (Gmt+09:00)
-
Korea Post plans to select multi-strategy fund of hedge fund managers
Korea Post’s insurance unit is preparing to pick global fund-of-hedge-fund managers using multi-strategy and will soon determine the amount of investm...
Mar 03, 2017 (Gmt+09:00)